Local use of GM-CSF for severe mucositis

European Journal of Cancer

Volumn 35, Issue SUPPL. 3, 1999, Pages 14-17

  Hejna, M ^a   Brodowicz, T ^a   Zielinski, C C ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ALPHA INTERFERON; ANTIMETABOLITE; ANTINEOPLASTIC ANTIBIOTIC; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DIPHENHYDRAMINE; DOXORUBICIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYUREA; IFOSFAMIDE; INTERLEUKIN 2; LIDOCAINE; MAGNESIUM HYDROXIDE; MERCAPTOPURINE; METHOTREXATE; MITHRAMYCIN; PROCARBAZINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SUCRALFATE; VINBLASTINE; VINCA ALKALOID; VINCRISTINE;

CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; LEUKOPENIA; MOUTH ULCER; MUCOSA INFLAMMATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

EID: 0032767360     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(99)00083-0     Document Type: Conference Paper

References (42)

1. Sonis S.T., Sonis A.L., Lieberman A. Oral complications in patients receiving treatment for malignancies other than of the head and neck. J. Am. Dent. Assoc. 97:1978;468-472.
2. Dreizen S, Brown LR. Oral microbial changes and infections during cancer chemotherapy. In Peterson DE, Sonis ST, eds. Oral Complications of Cancer Chemotherapy. Boston, Martinus-Nijhoff, 1983, 41-47.
3. Bodey G.P. Fungal infections complicating acute leukemia. J. Chronic. Dis. 19:1966;667-687.
4. Sonis A.L., Sonis S.T. Oral complications of cancer chemotherapy in pediatric patients. J. Pedodontics. 3:1979;122-128.
5. Dreizen S. Stomatotoxic manifestations of cancer chemotherapy. J. Prosthet. Dent. 40:1978;650-655.
6. Vogler W., Huguley C., Kerr W. Toxicity and antitumor effect of divided doses of methotrexate. Arch. Intern. Med. 115:1965;285-293.
7. Woo S.B., Sonis S.T., Sonis A.L. Oral herpes simplex virus infection in bone marrow transplant recipients. Cancer. 66:1990;2375-2379.
8. Dreizen S., McCredie K.B., Bodey G.P.N.et al. Quantitative analysis of the oral analysis of the oral complications of antileukemic chemotherapy. Oral Surg. 62:1986;650-653.
9. Lockhart P.B., Sonis S.T. Relationship of oral complications to the peripheral blood leukocyte and platelet counts in patients receiving cancer chemotherapy. Oral Surg. 48:1979;21-28.
10. Beck S. Impact of a systemic oral care protocol on stomatitis after chemotherapy. Cancer News. 2:1979;185-199.
11. Epstein J.B. Infection prevention in bone marrow transplantation and radiation patients. NCI Monograph. 9:1990;73-85.
12. Hickey A.J., Toth B.B., Lindquist S.B. Effect of intravenous hyperalimentation and oral care on the development of oral stomatitis during cancer chemotherapy. J. Prosthet. Dent. 47:1982;188-193.
13. Dreizen S., Bodey G.P., Rodriquez V. Oral complications of cancer chemotherapy. Postgrad. Med. 58:1975;95.
14. Sonis S., Kunz A. Impact of improved dental services on the frequency of oral complications for patients with non-head and neck malignancies. Oral Surg. Oral Med. Oral Pathol. 65:1988;19-21.
15. Carl W., Emrich L.S. Management of oral mucositis during local radiation and systemic chemotherapy. a study of 98 patients J. Prosthet. Dent. 66:1991;361-369.
16. Ferretti G.A., Ash R.C., Brown A.T.et al. Chlorhexidine in prophylaxis against oral infections and associated complications in patients receiving bone marrow transplantation. J. Am. Dent. Assoc. 114:1987;292-294.
17. Williford S.K., Salisbury P.L., Peacock J.F.et al. The safety of dental extractions in patients with hematologic malignancies. J. Clin. Oncol. 7:1989;798-802.
18. Epstein J.B., Pearsall N.N., Truelove E.L. Oral candidiasis. effects of antifungal therapy upon clinical signs and symptoms, salivary antibody and mucosal adherence of Candida albicans Oral Surg. 51:1981;32-36.
19. Taschdjian C.L., Kosinn P.H., Toni E.F. Opportunistic yeast infections with special reference to candidiasis. Ann. NY Acad. Sci. 174:1970;606-622.
20. Pizzuto J., Conte G., Aviles A.et al. Nystatin prophylaxis in leukemia and lymphoma. N. Engl. J. Med. 299:1978;661-662.
21. Carpentieri U., Haggard M.E., Lockhart L.H.et al. Clinical experience in preventions of candidiasis by nystatin in children with acute leukemia. J. Pediatr. 92:1978;593-595.
22. Mahhod D., Dose A.M., Lopirinzi C.et al. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J. Clin. Oncol. 9:1991;449-452.
23. Clark P.I., Slevin M.L. Allopurinol mouthwashes and 5-fluorouracil induced oral toxicity. Eur. J. Surg. Oncol. 11:1985;267-268.
24. Tsavaris N., Cargiauris P., Kosmidis P. Reduction of oral toxicity of 5-fluorouracil by allopurinol mouthwashes. Eur. J. Surg. Oncol. 14:1988;405-406.
25. Pfeiffer P., Madsen E.L., Hansen O., May O. Effect of prophylactic sucralfate suspension on stomatitis induced by cancer chemotherapy. Acta Oncol. 29:1990;171-173.
26. Kubley G.J., Chapman B., Chapman S.K.et al. Effect of acyclovir on radiation and chemotherapy-induced mouth lesions. Antimicrob. Agents Chemother. 33:1989;862-865.
27. Kuehrer I., Kuzmits R., Linkesch W.et al. Topical PGE2 enhances healing of chemotherapy-associated mucosal lesions. Lancet. 1:1986;623.
28. Walleigh R., Redman R., Cohen M.et al. Vitamin E in the treatment of chemotherapy-induced mucositis. Proc. ASCO. 9:1990;320.
29. Franco J.A., Appelbaum F.R., Nemunaitis J.et al. Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood. 78:1991;1205-1211.
30. LaVeque F.G., Parzuchowski J.B., Farinacci G.C.et al. Clinical evaluation of benzocaine, an anesthetic, film-forming agent for relief from painful oral ulcers associated with chemotherapy. J. Clin. Oncol. 10:1992;1963-1968.
31. Neema J.P., Baboo H.A., Shah P.M. Radiation mucositis. prevention and treatment with special reference to the use of GM-CSF J. Assoc. Physicians India. 3:1995;14.
32. Symonds R.P. Treatment-induced mucositis: an old problem with new remedies. Br. J. Cancer. 77:1998;1689-1695.
33. Masucci G. New clinical applications of granulocyte-macrophage colony-stimulating factor. Med. Oncol. 13:1996;149-154.
34. Ausili-Cefaro G, Marmiroli L, Fincato G, et al. Comparison between rhGM-CSF and rhG-CSF administered during radiotherapy and after prolonged carboplatin infusion in preventing leukopenia and mucositis produced by chemoradiotherapy in advanced head and neck cancer. Eur J Cancer 1995, 31A(Suppl. 5), S56, Abstract 255.
35. Chi K.H., Chen C.H., Chan W.K.et al. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. J. Clin. Oncol. 13:1995;2620-2628.
36. Kannan V., Bapsy P.P., Anantha N.et al. Efficacy and safety of granulocyte macrophage-colony stimulating factor on the frequency and severity of radiation mucositis in patients with head and neck carcinoma. Int. J. Rad. Oncol. Biol. Phys. 37:1997;1005-1010.
37. Ovilla-Martinez R, Rubio ME, Borbolla JR, et al. GM-CSF mouthwashes as treatment for mucositis in BMT patients. Blood 1994, 84(10), Abstract 2853.
38. Cartee L., Petros W.P., Rosner G.L.et al. Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis. a randomized, double-blind, dose-ranging study Cytokine. 7:1995;471-477.
39. Haus U, Quietzsch D, Faerber L, Dittrich H. Effect of rh-granulocyte-macrophage colony-stimulating factor (GM-CSF) on oral mucositis. Ann Hematology 1996, 73(Suppl. II), A51, Abstract 203.
40. De La Torre A., Regueiro C.A., Valcarcel F.J. Granulocyte-macrophage colony-stimulating factor mouthwashes improve radiation induced mucositis in AIDS patients. Radiother. Oncol. 43:1997;229-230.
41. Cinat G, Mickiewicz E, Alvarez A, et al. Local use of GM-CSF in the treatment of severe mucositis. A preliminary trial. Proc ASCO 33rd Ann Mtg 1997, 8, 63a, Abstract 216.
42. Ibrahim EM, Al Mulhim FA. Use of granulocyte-macrophage colony-stimulating factor in chemotherapy-induced oral mucositis in non-neutropenic cancer patients. Proc ASCO 34th Ann Mtg 1998, 17, 87a, Abstract 335.